OMERS ADMINISTRATION Corp Invests $744,000 in The Cooper Companies, Inc. $COO

OMERS ADMINISTRATION Corp purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 10,372 shares of the medical device company’s stock, valued at approximately $744,000.

Other large investors have also recently added to or reduced their stakes in the company. Avalon Trust Co acquired a new stake in Cooper Companies during the second quarter worth $25,000. Root Financial Partners LLC raised its position in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares during the period. SJS Investment Consulting Inc. lifted its stake in shares of Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the last quarter. Elevation Wealth Partners LLC lifted its stake in shares of Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp purchased a new position in shares of Cooper Companies during the 2nd quarter worth $32,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of recent analyst reports. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. Needham & Company LLC reduced their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Finally, Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Stock Performance

Shares of COO stock opened at $70.96 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The stock has a market capitalization of $13.84 billion, a PE ratio of 60.14, a P/E/G ratio of 1.90 and a beta of 0.83. The firm has a 50 day moving average of $72.46 and a two-hundred day moving average of $70.88.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period last year, the business posted $0.96 earnings per share. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.